Efficacy of golimumab in the treatment of patients with ankylosing spondylitis (according to the data of a long-term follow-up)
The paper summarizes the data of a randomized placebo-controlled phase 3 GO-RAISE trial of spondylitis (AS) patients receiving two different doses (50 and 100 mg) of golimumab (GLM), which evaluates its efficiency and safety and X-ray progression of changes in the axial skeleton. In AS patients, GLM...
| Główni autorzy: | , , |
|---|---|
| Format: | Artykuł |
| Język: | Russian |
| Wydane: |
IMA-PRESS LLC
2015-03-01
|
| Seria: | Современная ревматология |
| Hasła przedmiotowe: | |
| Dostęp online: | https://mrj.ima-press.net/mrj/article/view/602 |